303 related articles for article (PubMed ID: 2537153)
1. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
[TBL] [Abstract][Full Text] [Related]
2. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B; Jonkers J; Acton D; Berns A
J Virol; 1997 Jan; 71(1):9-16. PubMed ID: 8985317
[TBL] [Abstract][Full Text] [Related]
3. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
6. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
Nature; 1989 Jul; 340(6228):61-3. PubMed ID: 2786994
[TBL] [Abstract][Full Text] [Related]
7. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
8. Expression of lymphomagenic oncogenes in T-cell lymphomas of HPV 16 transgenic mice.
Yang JT; Liu CZ; Domer P; Iannaccone P
Cancer Detect Prev; 1998; 22(5):405-15. PubMed ID: 9727621
[TBL] [Abstract][Full Text] [Related]
9. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
10. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
Sørensen IK; Kristiansen E; Mortensen A; van Kreijl C; Adamson RH; Thorgeirsson SS
Arch Toxicol Suppl; 1997; 19():377-86. PubMed ID: 9079225
[TBL] [Abstract][Full Text] [Related]
12. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression.
Jonkers J; Weening JJ; van der Valk M; Bobeldijk R; Berns A
Oncogene; 1999 Oct; 18(44):5982-90. PubMed ID: 10557087
[TBL] [Abstract][Full Text] [Related]
15. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.
van der Houven van Oordt CW; Schouten TG; van Krieken JH; van Dierendonck JH; van der Eb AJ; Breuer ML
Carcinogenesis; 1998 May; 19(5):847-53. PubMed ID: 9635873
[TBL] [Abstract][Full Text] [Related]
16. The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
Forshell LP; Li Y; Forshell TZ; Rudelius M; Nilsson L; Keller U; Nilsson J
Oncotarget; 2011 Jun; 2(6):448-60. PubMed ID: 21646687
[TBL] [Abstract][Full Text] [Related]
17. Elevated pim-1 and c-myc proto-oncogene induction in B lymphocytes from BLV-infected cows with persistent B lymphocytosis.
Stone DM; Norton LK; Magnuson NS; Davis WC
Leukemia; 1996 Oct; 10(10):1629-38. PubMed ID: 8847898
[TBL] [Abstract][Full Text] [Related]
18. Use of E mu-PIM-1 transgenic mice short-term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene, but not by TPA.
Kroese ED; Dortant PM; van Steeg H; van Oostrom CT; van der Houven van Oordt CW; van Kranen HJ; de Vries A; Wester PW; van Kreijl CF
Carcinogenesis; 1997 May; 18(5):975-80. PubMed ID: 9163683
[TBL] [Abstract][Full Text] [Related]
19. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
Breuer M; Wientjens E; Verbeek S; Slebos R; Berns A
Cancer Res; 1991 Feb; 51(3):958-63. PubMed ID: 1988138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]